Startups
Edit
Affymetrix
http://www.affymetrix.com/Last activity: 05.02.2025
Active - Reference to Applied Biosystems
Affymetrix is now part of Thermo Fisher Scientific. To see what’s new, go to https://www.linkedin.com/company/thermo-fisher-scientific
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with revenues of more than $20 billion and approximately 65,000 employees globally. Our mission is to enable our customers to make the world healthier, cleaner and safer. We help our customers accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. Through our premier brands – Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific and Unity Lab Services – we offer an unmatched combination of innovative technologies, purchasing convenience and comprehensive services. For more information, please visit www.thermofisher.com.
Overview
Employees
1001-5000
Phone
+55 11 97308-5541
Founded date
1992
Mentions in press and media 17
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 5, 2025 | Sequins™ Announces Availability of First Products - Bolsters Team for Commercialization | SAN FRANCISCO, Feb. 5, 2025 /PRNewswire/ -- Sequins, a newly-funded start-up in the next generation sequencing (NGS) ecosystem, announced today the availability of their first commercial products – the Sequins Metagenomics Core Control and ... |
| Jan 8, 2025 | Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Approved Immunotherapy Test | Chris Parker appointed CEO and Board Member Jarret Glasscock, founder and CEO, transitions to Chief Technology Officer (CTO), Board Member, and President ST. LOUIS–(BUSINESS WIRE)–January 8, 2025– Cofactor Genomics, Inc., a commercial-stage... |
| Jan 4, 2016 | Startup using genetics to enhance athletic performance | It just raised $1.55 million in seed funding to grow its Athletigen Performance Platform. The funding was led by Exponential Partners, and recently partnered with Affymetrix – a San Diego genotyping microarray company that helps Athletigen ... |
| Jul 20, 2015 | Cytox and Affymetrix Form Strategic Partnership to Develop and Commercialize Blood-Based Genetic Assay for Alzheimer’s Disease Risk Assessment | OXFORD, England–(BUSINESS WIRE)–July 20, 2015– Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, and Affymetrix (Nasdaq:AFFX), a leading provider of translational research and diagnostic solutions,... |
| Mar 22, 2013 | Analytics firm wants to help pharma improve the odds on “go/no go” decision with new drugs | Each team collects and analyzes the big data in genomics, identifies the drug’s complex target network of inside cells, projects its likelihood of advancing to the clinical trial stage and predicts the drug’s maximum efficacy for treating a... |
| Mar 28, 2012 | Stroke diagnosis company IschemiaCare planning clinical study | IschemiaCare’s blood test, called ISCDX, uses gene expression profiles to differentiate strokes that originate in the heart from those that originate in large blood vessels that lead to the brain. Typically, a stroke’s cause is diagnosed by... |
| Feb 12, 2010 | Ohio gets $19M in federal funds for health care job training | Promoted Clinical Care Capacity Planning Learn how to manage clinical care capacity more efficiently during uncertain times. SAP Promoted Telemedicine’s potential to provide healthcare to the world’s most vulnerable Teladoc Health Head of R... |
| Feb 29, 2008 | Decloaking 5AM’s stealthy ImmunoNewco — more details | (UPDATED: See below.) A few weeks ago, we broke the news that 5AM Ventures is nurturing a stealthy startup called — for now — ImmunoNewco. The trail led back to the Danish biotech Borean Pharma, which is developing protein-based drugs again... |
| Aug 19, 2007 | Personal-genetics startup Navigenics, a competitor to Google-backed 23andMe, unstealths | (UPDATED: See below.) Navigenics, a new personal genetics startup with some serious backing, threw back the curtain over the weekend by unveiling its Web site. The Redwood Shores, Calif., startup says it aims to provide individuals with the... |
Show more
Reviews 0
FAQ about Affymetrix
When was Affymetrix founded?
Affymetrix was founded in 1992.
What has the press written about Affymetrix?
Parsers VC has collected 17 articles mentioning Affymetrix, among them “Sequins™ Announces Availability of First Products - Bolsters Team for Commercialization” (Feb 5, 2025) and “Cofactor Genomics, Inc. Announces CEO Transition in Preparation for Accelerated Commercial Growth and Increased Patient Access for OncoPrism, its Medicare Ap...” (Jan 8, 2025).
Is Affymetrix still active?
Yes, Affymetrix is active; its latest activity on Parsers VC dates from Feb 5, 2025.